IL-10 promoter polymorphisms influence disease severity and course in psoriasis

Genes Immun. 2003 Sep;4(6):455-7. doi: 10.1038/sj.gene.6364004.

Abstract

We analyzed three single-nucleotide polymorphisms (SNPs) at the interleukin-10 (IL-10) 5' flanking region (positions -1082 A/G, -819 C/T and -592 C/A) in an association case-control study involving 248 patients with plaque type of psoriasis and 148 unrelated healthy volunteers using ARMS (amplification refractory mutation system)-PCR (Polymerase Chain Reaction) method. No difference was found in the frequencies of haplotype distribution between healthy controls and patients with psoriasis. There were no significant differences in the IL-10 haplotype distribution depending on the age of onset and family history of psoriasis. However, the results of our study demonstrate that the IL-10 haplotype has a role in determining severity and course of plaque type of psoriasis. IL-10 ACC haplotype (P<0.05) is likely to be defining lower activity of disease (PASI</=20; extent</=10%) and ATA haplotype is likely to be associated with persistent eruption (P<0.01). As ACC haplotype is suggested to be associated with high IL-10 secretion and ATA is related to low IL-10 secretion, potential differences in the IL-10 secretion levels might contribute the differences in the clinical course of psoriasis.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Disease Susceptibility
  • Female
  • Gene Expression Regulation
  • Genotype
  • Haplotypes
  • Humans
  • Interleukin-10 / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics*
  • Promoter Regions, Genetic / genetics*
  • Psoriasis / genetics*
  • Psoriasis / pathology
  • Severity of Illness Index

Substances

  • Interleukin-10